Reference: FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/ Summary: The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin […]
Reference: The NewERA. (2021, April 8). SAHPRA destroyed in court – Ivermectin available. Summary: On 8 April 2021, a significant court ruling declared that the South African Health Products Regulatory Authority (SAHPRA) could no longer restrict access to Ivermectin, a treatment believed to help with HIV and COVID-19. The High Court found SAHPRA’s actions to
Reference: Taniokal, H., Taniokal, S., & Kaga, K. (2021). Why COVID-19 is not so spread in Africa: How does Ivermectin affect it? medRxiv. https://doi.org/10.1101/2021.03.26.21254377 Summary: This article explores the low incidence of COVID-19 in Africa, investigating the potential effects of ivermectin, a treatment for onchocerciasis, on morbidity and mortality rates. A statistical analysis was conducted
Reference: Nakagami, H. (2021). Development of COVID-19 vaccines utilizing gene therapy technology. International Immunology, 33(10), 521–527. https://doi.org/10.1093/intimm/dxab013 Summary: The article discusses the urgent development of COVID-19 vaccines in response to the SARS-CoV-2 outbreak. Various vaccine technologies are being explored, categorised into four main groups: intact target viruses, proteins, viral vectors, and nucleic acids. RNA and
Reference: Yagisawa, M., Foster, P. J., Hanaki, H., & Ōmura, S. (2021). Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74(1), 44-73. https://doi.org/xxxxxx Summary: The article reviews the global response to the COVID-19 pandemic, particularly the role of ivermectin as a potential treatment. Initially regarded as ineffective, ivermectin gained
Reference: Yagisawa, M., Foster, P. J., Hanaki, H., & Ōmura, S. (2021). Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74(1), 44-75. Summary: The article reviews global clinical studies of ivermectin as a potential treatment for COVID-19. Initially, the outbreak was poorly communicated by the Chinese government, leading to
Reference: Bryant, A., Lawrie, T. A., Dowswell, T., Fordham, E., Hill, S., Mitchell, S., & Tham, T. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Proceedings and conclusions of the British Ivermectin Recommendation Development meeting held on the 20th February 2021 in Bath, United Kingdom. Evidence-Based Consultancy Medicine Ltd. Summary: The British
Reference: Musa, A. F. (2021). Tocotrienol: An underrated isomer of vitamin E in health and diseases. In Vitamin E in Health and Disease – Interactions, Diseases and Health Aspects. IntechOpen. https://doi.org/10.5772/intechopen.96451 Summary: This chapter explores tocotrienols, an often-overlooked form of vitamin E, highlighting their significant health benefits. Tocotrienols, found abundantly in palm oil, possess superior
Reference: British Ivermectin Recommendation Development. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Executive summary. Proceedings and conclusions of the British Ivermectin Recommendation Development meeting. Summary: The British Ivermectin Recommendation Development (BIRD) meeting, held on 20th February 2021 in Bath, aimed to evaluate ivermectin’s efficacy in treating and preventing Covid-19, especially in
Reference: Kory, P., Meduri, G. U., Iglesias, J., Varon, J., & Marik, P. E. (2021). Review of the emerging evidence supporting the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Front-Line COVID-19 Critical Care Alliance. Summary: This article by the Front Line COVID-19 Critical Care Alliance reviews the growing evidence supporting ivermectin’s effectiveness